SuperCom (SPCB) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SuperCom in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SPCB shares.
View SPCB analyst ratings or view top-rated stocks.

1 analysts have issued 1-year price targets for SuperCom's stock. Their SPCB share price forecasts range from $10.00 to $10.00. On average, they anticipate the company's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 809.2% from the stock's current price.
View analysts price targets for SPCB or view top-rated stocks among Wall Street analysts.

SuperCom's stock was trading at $1.78 at the beginning of the year. Since then, SPCB stock has decreased by 38.2% and is now trading at $1.0999.
View the best growth stocks for 2023 here.

SuperCom saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 64,900 shares, a decrease of 28.8% from the April 30th total of 91,200 shares. Based on an average daily volume of 62,100 shares, the short-interest ratio is currently 1.0 days. Approximately 1.2% of the shares of the stock are sold short.
View SuperCom's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our SPCB earnings forecast.

SuperCom Ltd. (NASDAQ:SPCB) posted its earnings results on Thursday, April, 20th. The industrial products company reported $0.53 EPS for the quarter. The industrial products company earned $5.12 million during the quarter. SuperCom had a negative net margin of 31.24% and a negative trailing twelve-month return on equity of 30.61%.

SuperCom's stock reverse split before market open on Monday, November 21st 2022. The 1-10 reverse split was announced on Monday, November 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

4 employees have rated SuperCom Chief Executive Officer Frank C.W. Luk on Glassdoor.com. Frank C.W. Luk has an approval rating of 48% among the company's employees. This puts Frank C.W. Luk in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other SuperCom investors own include Sorrento Therapeutics (SRNE), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Heat Biologics (HTBX), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Nokia Oyj (NOK), Novan (NOVN), Aeterna Zentaris (AEZS) and CBL & Associates Properties (CBL).

SuperCom trades on the NASDAQ under the ticker symbol "SPCB."

SuperCom's stock is owned by many different retail and institutional investors. Top institutional investors include Armistice Capital LLC (11.11%).

Shares of SPCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SPCB stock can currently be purchased for approximately $1.10.

SuperCom (NASDAQ:SPCB) has a market capitalization of $4.63 million and generates $17.65 million in revenue each year. The industrial products company earns $-7,460,000.00 in net income (profit) each year or ($1.42) on an earnings per share basis.

SuperCom's mailing address is 20 LINCOLN STREET, TEL AVIV L3, 6713412. The official website for the company is www.supercom.com. The industrial products company can be reached via phone at (729) 889-0850, via email at ir@supercom.com, or via fax at 972-9889-0820.